Literature DB >> 35870051

Correction: Infant formulas with synthetic oligosaccharides and respective marketing practices: Position Statement of the German Society for Child and Adolescent Medicine e.V. (DGKJ), Commission for Nutrition.

Christoph Bührer1, Regina Ensenauer2, Frank Jochum3, Hermann Kalhoff4, Berthold Koletzko5, Burkhard Lawrenz6, Walter Mihatsch7, Carsten Posovszky8, Silvia Rudloff9.   

Abstract

Entities:  

Year:  2022        PMID： 35870051      PMCID： PMC9308842          DOI： 10.1186/s40348-022-00147-x

Source DB:  PubMed          Journal:  Mol Cell Pediatr        ISSN： 2194-7791


× No keyword cloud information.
Correction: Mol Cell Pediatr 9, 14 (2022) https://doi.org/10.1186/s40348-022-00146-y Following publication of the original article [1], authors would like to correct the article title. The correct article title is given below: Infant formulas with synthetic oligosaccharides and respective marketing practices: Position Statement of the German Society for Child and Adolescent Medicine e.V. (DGKJ), Commission for Nutrition. The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.
  1 in total

1.  Infant formulas with synthetic oligosaccharides and respective marketing practices.

Authors:  Christoph Bührer; Regina Ensenauer; Frank Jochum; Hermann Kalhoff; Berthold Koletzko; Burkhard Lawrenz; Walter Mihatsch; Carsten Posovszky; Silvia Rudloff
Journal:  Mol Cell Pediatr       Date:  2022-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.